SAN FRANCISCO, Dec. 17, 2015 – Zephyr Health, the leading insights-as-a-service company in the healthcare industry, today announced that it has been selected for two prestigious industry awards; PM360’s “The Most Innovative Start-ups in 2015” and Insights Success’ “The 20 Most Valuable Enterprise Big Data Companies.”
“We are honored to be selected for these awards and to be recognized as a game-changing technology player,” said William King, founder and executive chairman, Zephyr Health. “It’s thrilling to see Zephyr Illuminate’s unique offering for Life Sciences companies being recognized both by the Biopharma and the big data, technology community.”
Zephyr Health was selected as one of the Most Innovative Start-ups in 2015 by PM360 based upon how Zephyr IlluminateTM is harnessing global health data to provide a holistic view of treatment and market landscape for Life Sciences companies and help commercial leaders make confident decisions faster across the entire product lifecycle with precise and predictive customer and market insights. PM360 is a publication for marketing decision makers in the pharmaceutical, biotech and medical device industries.
Zephyr Health was named as one of the 20 Most Valuable Enterprise Big Data Companies by Insights Success for the ability of Zephyr Illuminate to aggregate the largest global dataset so that Life Sciences leaders can have the most complete view of their customers. Zephyr Illuminate has patented, machine learning algorithms that use advanced and predictive analytics to filter, aggregate, organize and visualize meaningful insights – on demand. Insights Success is a business solutions magazine that focuses distinctively on emerging as well as leading tech companies.
About Zephyr IlluminateTM
Zephyr Illuminate is the only insights-as-a-service solution that integrates global health data from thousands of disconnected sources to provide precise and predictive customer and market insights for Life Sciences companies so that they can make confident decisions faster across the entire product lifecycle.
About Zephyr Health
Founded in 2011, Zephyr Health is the leading insights-as-a-service company harnessing the power of global health data to address critical business and patient needs. From clinical trials to market strategy and sales performance, Zephyr Illuminate™ helps Life Sciences companies make confident decisions faster across the entire product lifecycle with precise and predictive market insights. Zephyr Health's customers include Fortune 100 biopharmaceutical, diagnostic and medical device companies like Amgen, Genentech, Gilead, Medtronic and Onyx.
Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India. Zephyr Health is venture backed by Google Ventures, Kleiner Perkins Caufield & Byers and Icon Ventures.